HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Connect Life Sciences Appoints Megan Driscoll as Executive Chairman

Created at 1 Jun · 2:37 PM1 source
IN SHORT

Connect Life Sciences (CLS) announced Megan Driscoll as the new Executive Chairman of its Board of Directors. CLS is a portfolio company of Argosy Healthcare Partners (AHP) and operates in life sciences recruitment.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Who's Involved

Megan Driscoll
Newly appointed Executive Chairman of Connect Life Sciences' Board of Directors
Connect Life Sciences (CLS)
Life sciences recruitment company
Argosy Healthcare Partners (AHP)
Investment firm and parent company of CLS

↳ Why This Matters

This appointment signifies a leadership change at Connect Life Sciences, a company focused on recruitment within the life sciences sector. As Executive Chairman, Driscoll will likely play a key role in the strategic direction and governance of CLS, which is backed by Argosy Healthcare Partners.

Key facts

  • Megan Driscoll has been appointed Executive Chairman of Connect Life Sciences' Board of Directors.
  • Connect Life Sciences (CLS) is a life sciences recruitment company.
  • CLS is a portfolio company of Argosy Healthcare Partners (AHP).

This appointment signifies a leadership change at Connect Life Sciences, a company focused on recruitment within the life sciences sector. As Executive Chairman, Driscoll will likely play a key role in the strategic direction and governance of CLS, which is backed by Argosy Healthcare Partners.

Frequently asked questions

Megan Driscoll is the newly appointed Executive Chairman of the Board of Directors at Connect Life Sciences.

Connect Life Sciences (CLS) is a company specializing in recruitment within the life sciences industry.

Connect Life Sciences is a portfolio company of Argosy Healthcare Partners (AHP).

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

How It Developed

1 Jun · 2:03 PM
Connect Life Sciences has appointed Megan Driscoll as Executive Chairman of its Board of Directors.
PRN | All News Releases via PiQSuite

Sources

T1
Connect Life Sciences Appoints Megan Driscoll as Executive Chairman of the Boardm.piqsuite.com

Related Stories

Visionary Homes names Ryan Smith CEO, Jeff Jackson to become chairman
8 Jul · 8:15 PM
Air Canada CEO to Retire After Language Controversy
8 Jul · 3:25 PM
Fiserv President Dhivya Suryadevara Resigns
8 Jul · 3:30 PM
Ashley Smith launches $25M fund for AI, security startups
8 Jul · 3:30 PM
Evan Dean joins NGFA as vice president, government and legislative affairs
8 Jul · 3:10 PM